前列腺方治疗慢性前列腺炎血瘀证的临床与实验研究

目的：验证前列腺方（汤剂及胶囊）的临床疗效及作用机理。方法：用前列腺汤剂和前列腺胶囊分别治疗慢性前列腺炎血瘀证３２２例和２３９例患者，并与用前列康片治疗的９５例作对照，观察治疗前后前列腺液（ＥＰＳ）－ｐＨ值及锌（ＥＰＳ－Ｚｎ）含量，并与用前列康片治疗的９５例作对照，观察治疗前后前列腺液（ＥＰＳ）－ＰＨ值及锌（ＥＰＳ－Ｚｎ）含量，并进行动物血液流变学及微循环观察。结果：汤剂组、胶囊组和对照组临床治愈

Study on Treatment of Blood Stasis Syndrome of Chronic Prostatitis Using Prostatitis Decoction and its Extract Capsule

Objective: To test and verify the effects of prostatitis decoction and its capsule on the treatment of chronic prostatitis with blood stasis Syndrome, and its therapeutic mechanism. Methods: Five hundred and sixty one Patients were treated for 2 months, decoction group 322 cases, and capsule group 239 cases. As control group, 95 cases were treated with Qianliekang tablets. Expressed prostatic secretion(EPS) pH and Zn content were measured before and after treatment. Observation on hemorheology and microcirculation disturbance with animal experiments were conducted. Results: The cure rate of Prostatitis decoction and capsule groups was 65.8%, and 54.4% respectively, that of control group was only 17.9%. EPS pH and Zn were markedly improved after Prostatitis decoction treatment. Experimental work revealed that Prostatitis decoction and its capsule had lowered the whole blood viscosity, thrombocyte adhesiveness rate and dry weight of thrombus in blood stasis rabbit model; and on rats model of microcirculation disturbance caused by adrenalin, the Prostatitis decoction and its capsules had obviously delayed the occurrence of reduction and stopping of blood flow in arterioles. Conclusion: Prostatitis decoction (capsule) was effective in treating chronic prostatitis.